European approval as class III medical device:
- TASECTAN DUO® is intended to restore the physiological function of the intestinal wall as well as to prevent and alleviate dysbacteriosis of different nature and origin.
- TASECTAN DUO® is indicated for the prevention and treatment of digestive disorders as diarrhoea and other related symptoms such as bloating and abdominal tension, as a result of infectious gastroenteritis, antibiotic treatments and chemotherapy among others, being effective within the first 12 hours. TASECTAN DUO® contributes to restore the optimal gut conditions to promote growth of the endogenous intestinal flora thus contributing to improve the natural defenses of the organism.
TASECTAN DUO® is available in powder sachets for paediatric use and tablets for adults use. TASECTAN DUO® is already marketed in European countries.